Aprea Therapeutics, Inc. Research And Development Expense

Quick Answer

Aprea Therapeutics, Inc. reported Research And Development Expense of $23.90 million for the year ending 2021.

  • Aprea Therapeutics, Inc. showed a decrease of -36.9% in Research And Development Expense from 2020 to 2021.
  • This data is from Aprea Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 15, 2022.
  • XBRL data for this metric is available from 2017 to 2021 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2017 to 2021), Aprea Therapeutics, Inc.'s Research And Development Expense has grown by 78.4%.
  • Historical annual values: Fiscal year 2021: $23.90 million | Fiscal year 2020: $37.88 million | Fiscal year 2019: $20.95 million | Fiscal year 2018: $14.19 million | Fiscal year 2017: $13.39 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: